MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program

Xu Monette, Zy; Møller, Mb; Tzankov, A; Montes Moreno, S; Hu, W; Manyam, Gc; Kristensen, L; Fan, L; Visco, C; Dybkaer, K; Chiu, A; Tam, W; Zu, Y; Bhagat, G; Richards, Kl; Hsi, Ed; Choi, Ww; van Krieken, Jh; Huang, Q; Huh, J; Ai, W; Ponzoni, Maurilio; Ferreri, Aj; Wu, L; Zhao, X; Bueso Ramos, Ce; Wang, Sa; Go, Rs; Li, Y; Winter, Jn; Piris, Ma; Medeiros, Lj; Young, Kh